Raymond James raises MSCI stock price target on strong Q3 results

Raymond James raised its MSCI price target to $680 from $660 and maintained a Strong Buy rating, citing Q3 2026 results and evidence that AI-native solutions are shortening product development times and broadening customer use cases. Adjusted EPS of $5.11 topped the $5.02 forecast, while revenue of $892 million exceeded the $887.82 million estimate; Raymond James said the quarter could increase confidence in long-term revenue durability and support a valuation re-rating. InvestingPro, however, lists the stock as overvalued relative to its Fair Value.

Analysis

The key read-through is not the quarterly beat; it is whether AI features turn into durable paid usage and recurring sales rather than faster product development alone. If customers adopt incremental use cases without weakening pricing, MSCI can support a richer growth multiple. But the evidence cited is still early: a single stronger quarter does not resolve the recent choppiness in net new recurring sales, and an analyst target increase is not independent proof of monetization.

Near term, positive results and upward estimate revisions can support the shares, but valuation leaves less room for another soft recurring-sales print. Over the next 1–3 months, track net new recurring sales, subscription growth, retention/pricing commentary, and whether AI use cases convert into contracted revenue. Over 6–18 months, successful AI monetization could strengthen MSCI’s position in workflows where switching costs matter; conversely, easier-to-build analytics may lower barriers for competitors such as S&P Global and FactSet, making pricing and retention more important than feature launches. Private-capital strength is a separate growth lever, but should not be treated as proof that AI is driving consolidated results.

The contrarian risk is that investors capitalize efficiency claims before revenue conversion is measurable, while the cited valuation metrics use different earnings bases and are not directly comparable. The thesis weakens if recurring sales remain choppy, management does not demonstrate paid AI adoption, or guidance/retention softens.

Key Decisions for Investors

• Do not chase the target increase alone. For existing MSCI exposure, hold rather than add aggressively until the next update shows sustained improvement in net new recurring sales and evidence that AI use cases generate paid, retained revenue.
• For a new long, use a pullback or post-results consolidation as the entry window; size modestly and add only if recurring-sales momentum and subscription growth confirm. No defensible price level can be set from the supplied information.
• Set a thesis review trigger around the next earnings disclosure: reassess if recurring sales weaken again, guidance or retention trends deteriorate, or AI commentary remains focused on development speed without customer conversion.
• Watch S&P Global and FactSet commentary for evidence that competing data and analytics providers are matching AI functionality or using it to pressure pricing; that would undermine the assumption that MSCI captures durable incremental economics.